INTEGRAL DIAGNOSTICS LIMITED (IDX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IDX - INTEGRAL DIAGNOSTICS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX300 | ALL-ORDS

Integral Diagnostics is an Australian healthcare services company providing diagnostic imaging services to medical practitioners in Australia and New Zealand. It has been a listed company since 2015.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.74

05 Dec
2022

0.030

OPEN

$2.78

1.11%

HIGH

$2.79

180,245

LOW

$2.72

TARGET
$2.832 3.4% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . PEB . AT1 . CBL .
FNARENA'S MARKET CONSENSUS FORECASTS
IDX: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 7.0 12.1 xxx
DPS (cps) xxx 7.0 8.1 xxx
EPS Growth xxx - 55.2% 74.0% xxx
DPS Growth xxx - 43.2% 16.2% xxx
PE Ratio xxx N/A 22.6 xxx
Dividend Yield xxx N/A 3.0% xxx
Div Pay Ratio(%) xxx 100.3% 67.0% xxx

Dividend yield today if purchased 3 years ago: 1.93%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.58

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 01/09 - ex-div 3c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx7.0
DPS All xxxxxxxxxxxxxxx7.0
Sales/Revenue xxxxxxxxxxxxxxx358.7 M
Book Value Per Share xxxxxxxxxxxxxxx151.6
Net Operating Cash Flow xxxxxxxxxxxxxxx37.1 M
Net Profit Margin xxxxxxxxxxxxxxx4.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx4.85 %
Return on Invested Capital xxxxxxxxxxxxxxx2.40 %
Return on Assets xxxxxxxxxxxxxxx2.03 %
Return on Equity xxxxxxxxxxxxxxx4.85 %
Return on Total Capital xxxxxxxxxxxxxxx6.15 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-11.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.1

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

5

xxxxxxxxx xx xxxxxxxxxxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

25/10/2022

3

Neutral

$2.83

3.28%

Integral Diagnostics has terminated its Exact Radiology acquisition, and Macquarie has subsequently removed the previously estimated 5% annualised earnings per share accretion. 

Despite industry commentary pointing to improved diagnostic imaging activity, Macquarie remains cautious on Integral Diagnostics' near-term outlook given higher operating costs and challenges in New Zealand. 

The Neutral rating is retained and the target price decreases to $2.83 from $3.18.

FORECAST
Macquarie forecasts a full year FY23 dividend of 7.00 cents and EPS of 12.40 cents.
Macquarie forecasts a full year FY24 dividend of 9.00 cents and EPS of 15.70 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

4

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

IDX STOCK CHART